(Q37754520)

22 August 2017

title

The origin and pathogenic consequences of anti-dsDNA antibodies in systemic lupus erythematosus (English)

1 reference

systemic lupus erythematosus

22 August 2017

1 reference

1 reference

2

David A Isenberg

1 reference

22 August 2017

Jessica J Manson

1

1 reference

22 August 2017

publication date

1 May 2006

1 reference

Expert Review of Clinical Immunology

22 August 2017

published in

1 reference

22 August 2017

volume

2

1 reference

22 August 2017

issue

3

1 reference

22 August 2017

page(s)

377-385

1 reference

Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Immunopathologic studies of systemic lupus erythematosus. II. Antinuclear reaction of gamma-globulin eluted from homogenates and isolated glomeruli of kidneys from patients with lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Natural serum IgM maintains immunological homeostasis and prevents autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Genetic and structural evidence for antigen selection of anti-DNA antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Systematic analysis of sequences of anti-DNA antibodies--relevance to theories of origin and pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence, binding properties, and pathogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Concomitant early appearance of anti-ribonucleoprotein and anti-nucleosome antibodies in lupus prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Anti-chromatin antibodies in systemic lupus erythematosus: a useful marker for lupus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

The classification of glomerulonephritis in systemic lupus erythematosus revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Alpha-actinin-4-mediated FSGS: an inherited kidney disease caused by an aggregated and rapidly degraded cytoskeletal protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Lupus anti-DNA autoantibodies cross-react with a glomerular structural protein: a case for tissue injury by molecular mimicry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Cross-reactivity of human and murine anti-DNA antibodies with heparan sulfate. The major glycosaminoglycan in glomerular basement membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL/lpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Systemic exposure to irradiated apoptotic cells induces autoantibody production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Features of systemic lupus erythematosus in Dnase1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Decreased phagocytosis of apoptotic cells in diseased SLE mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Crystal structure of the nucleosome core particle at 2.8 A resolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus. Correlation with serum antinucleosome antibody titers and absence of clear association with disease activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Human IgG anti-DNA antibodies deposit in kidneys and induce proteinuria in SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Plasma levels of nucleosomes and nucleosome-autoantibody complexes in murine lupus: effects of disease progression and lipopolyssacharide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Histone-containing immune complexes are to a large extent responsible for anti-dsDNA reactivity in the Farr assay of active SLE patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

Higher anti-heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.2.3.377

21 January 2018

Identifiers

DOI

10.1586/1744666X.2.3.377

1 reference

22 August 2017

1 reference